About NovaBone
NovaBone is a Healthcare company based in Alachua (United States) founded in 2002, and was acquired by Halma in January 2020. Bone graft substitutes are developed for orthopedic and dental surgeries. The company has 3 employees. NovaBone offers products and services including NovaBone Putty, Orthopedics Products, and Dental Products. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity in India is Novabone Products Private Limited (U51397KA2012PTC062127). Its competitors include MiMedx Group, EpiBone and Theradaptive; 2 of its 3 listed competitors have raised funding.
Company details
NovaBone develops bone graft substitutes to fulfill the needs of orthopedic and dental surgeons. It is a calcium phospho-silicate composed of elements naturally occurring in the body and it accelerates natural bone growth. The technology, osteostimulation, involves an ionic release of Si, Ca and phosphate ions results in the stimulation a family of genes that are known to be critical to repair and regeneration of bone tissue.
- Headquarters Alachua, United States
- Employees 3
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website novabone.com
- Social LinkedIn
- Acquired by Halma (Jan 2020)
- Legal Name Novabone Products Private Limited
- Date of Incorporation 18 Jan, 2012
- Jurisdiction Bangalore, Karnataka, India
Associated legal entities of NovaBone
NovaBone operates through Novabone Products Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Novabone Products Private Limited CIN U51397KA2012PTC062127 | Active | 18 Jan 2012 | Bangalore, Karnataka | ₹0.0 Cr | 3 | 4 | View details |
Products & Services of NovaBone
NovaBone offers a comprehensive portfolio of products and services, including NovaBone Putty, Orthopedics Products, and Dental Products.
Material for filling osseous defects in orthopedic and dental surgeries
Devices supporting bone healing in orthopedic applications
Products for dental procedures like implants and grafting
Funding Insights of NovaBone
- Total Rounds 2
- Last Round Grant — $145,511
- First Round $145,511
(Nov 2009)
- Investors Count 1
All 2 funding rounds of NovaBone with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2010 | $145,511 | Grant | – | – | |
| Nov 2009 | $145,511 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in NovaBone
NovaBone has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Halma and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Safety, health, and environmental technologies are developed and supplied internationally. | 1894 | halma.com | Amersham, United Kingdom |
Investor details for NovaBone
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Novabone Products Private Limited (NovaBone)
Novabone Products Private Limited is the primary company behind NovaBone. The board of Novabone Products Private Limited currently have 4 directors; the longest-serving is Radhika, appointed in 2012. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Radhika DIN 05147461 | Director | 18 Jan 2012 | 14 yrs 9 mo | Novabone Products Private Limited |
| Katta Narayanaiah Aswathanarayanagupta DIN 07965460 | Director | 16 Oct 2017 | 9 yrs | Novabone Products Private Limited |
| Susheela Aswath Katta DIN 09093769 | Director | 05 Mar 2021 | 5 yrs 7 mo | Novabone Products Private Limited |
| Sunitha Bagepalli Ashwathanarayana DIN 11537635 | Additional Director | 13 Feb 2026 | 8 mo | Novabone Products Private Limited |
Financials of NovaBone
Figures of Novabone Products Private Limited, the primary company behind NovaBone, for FY 2025. Revenue was ₹4,988 (-29% year on year). Net loss was -₹30.6 Lakh (-61388% margin). EBITDA was -₹28.8 Lakh (-57752% margin). Revenue has grown at a compounded annual rate of +118% over three years and -85% over five years.
- ₹4,988Revenue · FY 2025 · -29% YoY
- -₹30.6 LakhNet loss · -61388% margin
- -₹28.8 LakhEBITDA · -57752% margin
- ₹1.7 LakhPaid-up capital
- 3Employees (provident fund records)
- +118%Revenue CAGR, 3 years
- -85%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Novabone Products Private Limited are on its company page.
Detailed financial statements for NovaBone
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of NovaBone
4 dated milestones of NovaBone across 18 years, from founding to its latest funding, stage changes and deals.
- Founded NovaBone is founded.
- Funding First funding round of $146K.
- Funding Latest funding round, Grant, of $146K.
- Exit Acquired by Halma.
Competitors of NovaBone
NovaBone has 3 listed competitors in our database, 2 of them funded. They include MiMedx Group, EpiBone and Theradaptive.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mimedx.com | 1985 | Marietta, United States | 735 | Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | ||
| epibone.com | 2013 | Brooklyn, United States | $48.63M | Developer of stem cells to regrow damaged bones | ||
| theradaptive.com | 2004 | Boston, United States | $32.2M | 21 | Therapeutic delivery platform is developed for orthopedic clinical indications. |
Detailed competitors of NovaBone
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NovaBone
The website of NovaBone (novabone.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 40.4% vs previous month
Top companies in Orthopedics
3 companies that operate in the same segment as NovaBone (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novabone
Complete news archive for NovaBone
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NovaBone
NovaBone was founded in 2002 and raised its 1st funding round 7 years after it was founded.
NovaBone is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.
NovaBone has 3 employees.
The primary company behind NovaBone, Novabone Products Private Limited, reported revenue of ₹4,988 for FY 2025, down 29% year on year.
NovaBone develops bone graft substitutes to fulfill the needs of orthopedic and dental surgeons. It is a calcium phospho-silicate composed of elements naturally occurring in the body and it accelerates natural bone growth. The technology, osteostimulation, involves an ionic release of Si, Ca and phosphate ions results in the stimulation a family of genes that are known to be critical to repair and regeneration of bone tissue.
NovaBone's top competitors include EpiBone, Theradaptive and MiMedx Group.
NovaBone offers NovaBone Putty, Orthopedics Products, and Dental Products.
NovaBone has 2 investors. Key investors include Halma, and National Science Foundation.
NovaBone operates through Novabone Products Private Limited.
Yes. NovaBone was acquired by Halma in January 2020.
The legal entities of NovaBone currently have 4 directors, including Radhika, Susheela Aswath Katta, Katta Narayanaiah Aswathanarayanagupta and others.